Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Salivary Gland Adenoma, Pleomorphic × Acyclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Genitourinary 1

Conditions

Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Biphenotypic, Acute 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

carfilzomib 1 Dexamethasone 1 Acyclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02047253 2018-12-19

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

University of Alabama at Birmingham

Phase 2 Completed

28 enrolled 12 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡